DISCLOSURE:
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission at no extra cost to you. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network, Amazon and Alibris.
ISBN10: 354012392X, ISBN13: 9783540123927, [publisher: Berlin ; Heidelberg ; New York ; Tokyo : Springer] Softcover 403 p. Good condition. Reading pages are clean and without marks. Retired library exemplar, with the usual marking. Book shows slight signs of storage and usage. No dust jacket. Still good copy. 9783540123927 Sprache: Englisch Gewicht in Gramm: 1000 [Weinheim, Germany] [Publication Year: 1983]
Roland Antiquariat UG haftungsbeschränkt /AbebooksDE
ISBN10: 354012392X, ISBN13: 9783540123927, [publisher: Berlin ; Heidelberg ; New York ; Tokyo : Springer] Softcover 403 p. Good condition. Reading pages are clean and without marks. Retired library exemplar, with the usual marking. Book shows slight signs of storage and usage. No dust jacket. Still good copy. 9783540123927 Sprache: Englisch Gewicht in Gramm: 1000 [Weinheim, Germany] [Publication Year: 1983]
ISBN10: 354012392X, ISBN13: 9783540123927, [publisher: Springer Berlin Heidelberg] Softcover Druck auf Anfrage Neuware - Printed after ordering - Many chemotherapeutic agents introduced for use in humans are carcinogenic in laboratory animals (Conklin et al. 1965; Shimkin et al. 1966; Griswold et al. 1968; Harris 1976). However, initially their beneficial effect in disseminated cancer was of such short duration that the inevitable death of the patient from his primary disease precluded any clinical manifestation of the carcinogenic potential. During the last decade, chemotherapy has radically changed the outlook for many patients with cancer. Combinations of drugs, administered as the primary treatment, have resulted in high rates of cure in patients with disseminated malignancies, such as stage IV Hodgkin's disease or childhood acute lymphocytic leukemia. In other disseminated forms of neoplasia, induction of a remission, a substantial palliation and a prolongation of survival have been achieved. In many instances of localised disease, where surgery with or without radiotherapy are the primary form of treatment, anticancer drugs have been used with success as adjuvant therapy for distant microscopic disease. With these spectacular achievements, secondary malignancies, in particular acute non-lymphocytic leukemia (ANLL), has become of major concern. Incidence Acute leukemia is the most frequent form of secondary neoplasia in patients treated for cancer (Penn 1981 ...
ISBN10: 354012392X, ISBN13: 9783540123927, [publisher: Springer Berlin Heidelberg] Softcover Druck auf Anfrage Neuware - Printed after ordering - Many chemotherapeutic agents introduced for use in humans are carcinogenic in laboratory animals (Conklin et al. 1965; Shimkin et al. 1966; Griswold et al. 1968; Harris 1976). However, initially their beneficial effect in disseminated cancer was of such short duration that the inevitable death of the patient from his primary disease precluded any clinical manifestation of the carcinogenic potential. During the last decade, chemotherapy has radically changed the outlook for many patients with cancer. Combinations of drugs, administered as the primary treatment, have resulted in high rates of cure in patients with disseminated malignancies, such as stage IV Hodgkin's disease or childhood acute lymphocytic leukemia. In other disseminated forms of neoplasia, induction of a remission, a substantial palliation and a prolongation of survival have been achieved. In many instances of localised disease, where surgery with or without radiotherapy are the primary form of treatment, anticancer drugs have been used with success as adjuvant therapy for distant microscopic disease. With these spectacular achievements, secondary malignancies, in particular acute non-lymphocytic leukemia (ANLL), has become of major concern. Incidence Acute leukemia is the most frequent form of secondary neoplasia in patients treated for cancer (Penn 1981 ...
Paperback / softback. New. Many chemotherapeutic agents introduced for use in humans are carcinogenic in laboratory animals (Conklin et al. Combinations of drugs, administered as the primary treatment, have resulted in high rates of cure in patients with disseminated malignancies, such as stage IV Hodgkin's disease or childhood acute lymphocytic leukemia. ISBN 354012392x 9783540123927 [GB]
. Ed(s): Chambers, P. L.; Gitter, S.; Chambers, C. M.
USD
184.94
Kennys Bookstore /Abebooks
ISBN10: 354012392X, ISBN13: 9783540123927, [publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG] Softcover Editor(s): Chambers, P. L.; Gitter, S.; Chambers, C. M. Series: Archives of Toxicology. Num Pages: 406 pages, 27 black & white illustrations, biography. BIC Classification: MMG; MQP. Category: (P) Professional & Scholarly; (UP) Postgraduate; (UU) Undergraduate. Dimension: 244 x 170 x 21. Weight in Grams: 667. . 1983. Softcover reprint of the original 1st ed. 1983. Paperback. . . . . Books ship from the US and Ireland. [Olney, MD, U.S.A.] [Publication Year: 1983]
DISCLOSURE:
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission at no extra cost to you. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network, Amazon and Alibris.
